Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nonsurgical Management of Cesarean Scar Niche Related AUB
NCT05594186Completed
- Sponsor
- Saudi German Health
- Start
- Mar 2019
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of tranexamic acid, desogestrel, ethinyl estradiol and avatrombopag in abnormal uterine bleeding (AUB) (4 arms), sponsored by Saudi German Health. Primary endpoint: Improvement of post-menstrual spotting at 12 months. Started Mar 2019; status: completed.
02
Drugs
tranexamic aciddesogestrelethinyl estradiolavatrombopag
03
Conditions
abnormal uterine bleeding (AUB)
Beyond the preview
Go deeper on NCT05594186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05594186.